Neuronal HIF-1α and HIF-2α deficiency improves neuronal survival and sensorimotor function in the early acute phase after ischemic stroke P Barteczek, L Li, AS Ernst, LI Böhler, HH Marti, R Kunze Journal of Cerebral Blood Flow & Metabolism 37 (1), 291-306, 2017 | 122 | 2017 |
Inhibition of HIF prolyl-4-hydroxylases by FG-4497 reduces brain tissue injury and edema formation during ischemic stroke S Reischl, L Li, G Walkinshaw, LA Flippin, HH Marti, R Kunze PloS one 9 (1), e84767, 2014 | 121 | 2014 |
Thioredoxin-interacting protein (TXNIP) associated NLRP3 inflammasome activation in human Alzheimer’s disease brain L Li*, S Ismael*, S Nasoohi, K Sakata, FF Liao, MP McDonald, T Ishrat Journal of Alzheimer's Disease 68 (1), 255-265, 2019 | 103 | 2019 |
Neuronal deficiency of HIF prolyl 4-hydroxylase 2 in mice improves ischemic stroke recovery in an HIF dependent manner L Li*, P Saliba, S Reischl, HH Marti, R Kunze Neurobiology of disease 91, 221-235, 2016 | 51 | 2016 |
Fumaric acid esters promote neuronal survival upon ischemic stress through activation of the Nrf2 but not HIF-1 signaling pathway J Lin-Holderer, L Li, D Gruneberg, HH Marti, R Kunze Neuropharmacology 105, 228-240, 2016 | 41 | 2016 |
Inverse agonism of cannabinoid receptor type 2 confers anti-inflammatory and neuroprotective effects following status epileptics Y Yu, L Li, DT Nguyen, SM Mustafa, BM Moore, J Jiang Molecular neurobiology 57, 2830-2845, 2020 | 32 | 2020 |
Neuronal prolyl-4-hydroxylase 2 deficiency improves cognitive abilities in a murine model of cerebral hypoperfusion D Gruneberg, FA Montellano, K Plaschke, L Li, HH Marti, R Kunze Experimental Neurology 286, 93-106, 2016 | 28 | 2016 |
Prostaglandin E receptors as targets for ischemic stroke: Novel evidence and molecular mechanisms of efficacy L Li*, MN Sluter, Y Yu, J Jiang Pharmacological Research 163, 105238, 2021 | 26 | 2021 |
EP2 Antagonists (2011–2021): A Decade’s Journey from Discovery to Therapeutics MN Sluter*, R Hou*, L Li*, N Yasmen, Y Yu, J Liu, J Jiang Journal of Medicinal Chemistry 64 (16), 11816-11836, 2021 | 24 | 2021 |
Inhibiting the PGE2 receptor EP2 mitigates excitotoxicity and ischemic injury L Li*, Y Yu, R Hou, J Hao, J Jiang ACS Pharmacology & Translational Science 3 (4), 635-643, 2020 | 23 | 2020 |
Thioredoxin interacting protein regulates age-associated neuroinflammation S Ismael, S Nasoohi, L Li, KS Aslam, MM Khan, AB El-Remessy, ... Neurobiology of Disease 156, 105399, 2021 | 22 | 2021 |
White matter damage as a consequence of vascular dysfunction in a spontaneous mouse model of chronic mild chronic hypoperfusion with eNOS deficiency X Chen, L Chen, G Lin, Z Wang, MC Kodali, M Li, H Chen, SG Lebovitz, ... Molecular psychiatry 27 (11), 4754-4769, 2022 | 19 | 2022 |
Inducible Prostaglandin E Synthase as a Pharmacological Target for Ischemic Stroke L Li*, N Yasmen, R Hou, S Yang, JY Lee, J Hao, Y Yu, J Jiang Neurotherapeutics, 1-20, 2022 | 16 | 2022 |
Ablation of Siglec-E augments brain inflammation and ischemic injury L Li*, Y Chen*, MN Sluter, R Hou, J Hao, Y Wu, GY Chen, Y Yu, J Jiang Journal of Neuroinflammation 19 (1), 1-14, 2022 | 12 | 2022 |
Inhibition of TRPC3 channels by a novel pyrazole compound confers antiseizure effects MM Nagib, S Zhang, N Yasmen, L Li, R Hou, Y Yu, VK Boda, Z Wu, W Li, ... Epilepsia, 2022 | 10 | 2022 |
中医药治疗血管性痴呆临床近况 何婷婷, 张允岭, 金香兰, 高芳, 陈宝鑫, 张艳霞, 傅晨, 薛斐然, 牛焕敏, ... 北京中医药大学学报: 中医临床版 19 (3), 9-14, 2012 | 10 | 2012 |
Targeting EP2 receptor with multifaceted mechanisms for high-risk neuroblastoma R Hou, Y Yu, MN Sluter, L Li, J Hao, J Fang, J Yang, J Jiang Cell reports 39 (12), 2022 | 8 | 2022 |
Transient inhibition of microsomal prostaglandin E synthase-1 after status epilepticus blunts brain inflammation and is neuroprotective N Yasmen, MN Sluter, L Li, Y Yu, J Jiang Molecular Brain 16 (1), 14, 2023 | 7 | 2023 |
Acute Hyperglycemia Exacerbates Hemorrhagic Transformation after Embolic Stroke and Reperfusion with tPA: A Possible Role of TXNIP-NLRP3 Inflammasome M Salman*, S Ismael*, L Li*, HA Ahmed, MA Puchowicz, T Ishrat Journal of Stroke and Cerebrovascular Diseases 31 (2), 106226, 2022 | 7 | 2022 |
Prostaglandin receptor EP2 is a novel molecular target for high-risk neuroblastoma R Hou, Y Yu, DT Nguyen, MN Sluter, L Li, J Yang, J Jiang BioRxiv, 2020.02. 24.963108, 2020 | 3 | 2020 |